Nectar Lifesciences Limited has informed the Exchange regarding 'Disclosure Received In terms of Regulation 7(3) of SEBI(Prohibition Of Insider Trading) Regulation, 2015 ('PIT Regulations').'.
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SBICAP Trustee Company Limited, acting as Security Trustee for the lenders of Nectar Lifesciences, has released the pledge on 9,94,68,000 equity shares (44.35% of the company's shareholding) belonging to the promoters. The pledge release was triggered on 30 October 2025 because the company has fully repaid its loan to the lenders. The promoters and the company had already filed the required disclosures under Regulation 7(2) of the PIT Regulations. The disclosure was formally submitted to NSE and BSE on 3 November 2025.
This is a positive development for shareholders — the release of the pledge on such a large block of promoter shares (44.35%) reduces the risk of any forced selling and signals that the company has successfully deleveraged by repaying its lenders.